Open AccessPB2035: CAMMA 3: A MULTICENTER PHASE IB TRIAL EVALUATING THE SAFETY, PHARMACOKINETICS, AND ACTIVITY OF SUBCUTANEOUS CEVOSTAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
Author(s) -
Delimpasi S.,
Quach H.,
Cavo M.,
Ho P. J.,
Lee C. H.S.,
Santoro A.,
Schots R.,
Vlummens P.,
Yoon D. H.,
Yoon S.S.,
Santos C. D.,
Samineni D.,
Huang J.,
Wehrman K.,
Patil U.,
Sheikh S.,
Dimopoulos M. A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000850972.76878.85
Subject(s) - medicine , multiple myeloma , antibody , cytokine release syndrome , refractory (planetary science) , pharmacokinetics , lenalidomide , oncology , pharmacology , cancer , immunotherapy , immunology , chimeric antigen receptor , physics , astrobiology